Contact
Please use this form to send email to PR contact of this press release:
Immunovaccine Shareholders Approve Share Consolidation at 99.85%
TO:
Please use this form to send email to PR contact of this press release:
Immunovaccine Shareholders Approve Share Consolidation at 99.85%
TO: